Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion
Read More
Merck & Co Inc
Jim Cramer names hot sectors that could use a pullback
CNBC's Jim Cramer on Thursday named sectors that have seen major gains recently and warned investors not to buy them
Read More
These dividend-paying stocks could be in the ‘early innings’ of a rally
Wolfe Research says it's time to step back into health-care stocks. CNBC Pro screened for dividend-paying companies with upside potential.
Read More
‘Business Leaders for Harris’ campaign launches a podcast and website featuring Cuban, Hastings, Hoffman and more
Vice President Kamala Harris allies in the business community are trying to give her a boost over Donald Trump. Source
Read More
The one sector of the stock market that is cheap with upside today
Karen Firestone of Aureus Asset Management breaks down the case for biopharmaceuticals. Source link
Read More
What’s next for the Biden administration’s Medicare drug price negotiations
The Medicare negotiations are a multi-round process that could produce more savings for taxpayers and seniors and put more pressure
Read More
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but
Read More
These dividend payers will beat the yields on cash as the Fed cuts rates, Bank of America says
Yields on cash are going to tumble as interest rates drop. Dividend-paying stocks provide an opportunity for income, the firm
Read More
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance
Read More